Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bn

Bain Capital said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.

Feb 9, 2025 - 06:00

Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bn

Bain Capital said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.

Read the original article

Tags:

Previous Article

Revolutionizing Healthcare: The Future of Point-of-Care Diagnostics and Testing

Impact of proposed US tariffs on pharmaceutical FDI in Canada, Mexico, China and...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Sanofi and Biovac partner to produce polio vaccines in Africa

Sanofi and Biovac partner to produce polio vaccines in ...

Jun 22, 2024

Opinion: Doctors in states that ban abortion can still refer patients elsewhere. Why are so few doing that?

Opinion: Doctors in states that ban abortion can still ...

Jul 28, 2023

CymaBay maps out regulatory filing for primary biliary cholangitis drug seladelpar

CymaBay maps out regulatory filing for primary biliary ...

Sep 21, 2023